Navigation Links
NeoStem, Inc. Comments on Recent Selling Pressure
Date:5/28/2008

NEW YORK, May 28 /PRNewswire/ -- Responding to the decline in NeoStem, Inc.'s (Amex: NBS) market capitalization during the past four trading days, Robin Smith, CEO, NeoStem said, "We know of no business development at the Company that would lead to the sudden decline in our share price."

Dr. Smith continued, "As announced on May 21, 2008, we received a private placement financing in a total amount of $900,000, which includes a strategic investment from the New England Cryogenic Center, Inc., one of the largest full-service cryogenic laboratories in the world and participation by management. These funds will be instrumental in executing on our plans to educate potential clientele about our services, especially in the Northeast." The private placement was of units with each unit priced at $1.20 and consisting of one share of common stock and a warrant to buy one share of common stock at $1.75 per share.

In addition, on May 27, 2008, NeoStem announced that an agreement had been signed with the University of Louisville Hospital's James Graham Brown Cancer Center to become a NeoStem collection center for adult stem cells. NeoStem has now signed its first agreement with a hospital to become a stem cell collection center and it believes this unique corporate and academic relationship will assist in propelling the adult stem cell field forward.

"We remain extremely excited by the growth prospects for NeoStem and are pleased to see the recent article written by Alan Boyle, Science Editor, MSNBC, entitled "Stem Cell Banks Could Pay Medical Dividends." The link reference is http://www.msnbc.msn.com/id/24797415/

About NeoStem, Inc.

NeoStem has a growing nationwide network of adult stem cell collection centers, enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times of future medical need. The Company has also recently entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's periodic filings with the Securities and Exchange Commission. Further, the Company cautions that its very small embryonic-like (VSEL) stem cell technology is in early stages of research and the reference to Alan Boyle's article is only intended to show the interest in stem cell banking generally and not to imply anything about the Company's products and services. The Company's further development is highly dependent on future medical developments and market acceptance which is outside its control.

Contact:

NeoStem, Inc.

Robin Smith, Chief Executive Officer

T: 212-584-4180

E: rsmith@neostem.com

http://www.neostem.com


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lyme Lies: Allen Steeres horrifying comments regarding Lyme disease in last weeks commencement address
2. RNC RESPONSE TO OBAMA COMMENTS ON MEDICAL MARIJUANA LAWS
3. InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results
4. Xmark Comments on Genaera Cost-Saving Plan
5. Northfield Laboratories Inc. Comments on Article and Editorial on Hemoglobin-Based Blood Substitutes to be Published in May 21 JAMA
6. FRC Action Praises John McCains Pro-Life Comments
7. JAMA editor-in-chief comments on Pfizer lawsuit
8. Vital Images Comments on CMS Decision to Allow Local Coverage for Cardiac CT Angiography
9. Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
10. MGT Comments on American Cancer Societys Decision to Endorse CT Colonography
11. URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... 2017   West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today shared the results of a study ... the intradermal administration of polio vaccines. The study results ... May 2017 by Dr. Ondrej Mach , Clinical ... Organization (WHO), and recently published in the journal ...
(Date:10/4/2017)... 2017  According to the Centers for Disease Control and Prevention (CDC), ... PhysicianOne Urgent Care is helping communities across Massachusetts , ... by offering no-cost* flu shots through the end of the month. ... insurance regulations. ... get a flu shot is by the end of October, according to ...
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
Breaking Medicine Technology: